Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep;79(13):1485-1494.
doi: 10.1007/s40265-019-01188-9.

Selinexor: First Global Approval

Yahiya Y Syed  1
Affiliations
Review

Selinexor: First Global Approval

Yahiya Y Syed. Drugs. 2019 Sep.

Abstract

Selinexor (XPOVIO™) is a first-in-class, oral, small molecule Exportin-1 (XPO1) inhibitor that is being developed by Karyopharm Therapeutics for the treatment of cancer. Selinexor (in combination with dexamethasone) received accelerated approval in the USA in July 2019 for the treatment of adult patients with relapsed or refractory multiple myeloma (RRMM). Selinexor is also undergoing clinical development in a wide range of haematological and solid cancers. This article summarizes the milestones in the development of selinexor leading to this first approval for RRMM.

PubMed Disclaimer

References

    1. Cancer Res. 2017 Oct 15;77(20):5614-5627 - PubMed
    1. Cancer Lett. 2016 Dec 28;383(2):309-317 - PubMed
    1. Blood. 2017 Jun 15;129(24):3165-3174 - PubMed
    1. Oncotarget. 2016 Nov 29;7(48):78883-78895 - PubMed
    1. J Clin Oncol. 2016 Dec;34(34):4142-4150 - PubMed

MeSH terms

LinkOut - more resources